Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06068491Recruiting
Veteran-centered care for advanced liver disease
This study tests a new way of caring for veterans with advanced liver disease. It aims to help you manage your condition better and improve your quality of life.
Little Rock, ArkansasAges 18–80 - NCT06057181Recruiting
Helix research network for adults
This study is a research network that collects health information from adults to better understand health and disease. It is open to most adults who are willing to follow the study procedures.
Fort Wayne, IndianaAges 18 years+ - NCT05569122RecruitingPhase 1
Studying an MRI contrast method in mitochondrial muscle disease
This Phase 1 study tests a special MRI approach (using a contrast agent) to better measure changes in muscles in people with mitochondrial diseases. It also includes some healthy volunteers and other critically ill patients to compare results and check safety.
Philadelphia, PennsylvaniaAges 10–60 - NCT06078891Enrolling by invitationEarly Phase 1
BCG vaccine to lower Alzheimer's blood markers
This trial tests whether the BCG vaccine (a tuberculosis vaccine) can lower a blood marker linked to Alzheimer's disease. It is for people aged 70–80 who have slightly elevated p-tau181 levels but still have normal thinking and daily living skills.
JerusalemAges 70–80 - NCT06058585RecruitingPhase 3
Testing new treatments for chronic kidney disease
This study compares two experimental treatments—one that reduces protein in urine and another that may help control blood sugar and weight—for people with chronic kidney disease. It aims to find safer, more effective ways to slow kidney damage.
Garran, Australian Capital TerritoryAges 18 years+ - NCT06065436Recruiting
Shockwave therapy with collagenase for Peyronie's disease
This trial combines a low-intensity shockwave treatment with a commonly used injectable medication (collagenase) to see if the combination works better for men with Peyronie's disease who have a noticeable curve and a non-calcified plaque.
Rochester, MinnesotaAges 18 years+ - NCT06072079Enrolling by invitation
Structural chromosome changes and brain disorders
This trial is for people who have or might have a rare disease or a change in their chromosomes. The study aims to learn more about how these changes relate to brain disorders.
StockholmAges Any age - NCT00792155Recruiting
Register people with diagnosed ADPKD to build a kidney data resource
This trial builds a secure database by collecting information from adults who already have autosomal dominant polycystic kidney disease (ADPKD). Your information can help researchers understand the condition better and improve future care.
New York, New YorkAges 18 years+ - NCT06033924Recruiting
Home Walking Program for Vets with Leg Artery Disease
This study tests a home-based walking program delivered through telehealth for Veterans with peripheral artery disease (PAD). It aims to help you walk farther with less pain.
Birmingham, AlabamaAges 21 years+ - NCT05113095Recruiting
Survey of Darvadstrocel in Crohn’s with fistulas
This is a survey study in people with Crohn’s disease who have complex perianal fistulas and have already received Darvadstrocel. It aims to understand how patients are doing after treatment and gather real-world feedback.
Tokyo, TokyoAges 20 years+ - NCT06041880Recruiting
Calf Stretching for Better Walking in PAD
This study tests whether a simple daily calf-stretching routine can improve walking ability and blood flow in people with peripheral artery disease. It offers a non-drug, non-surgical approach that you can do at home.
University Park, PennsylvaniaAges 40–85 - NCT06052163RecruitingPhase 2
Testing bumetanide for early Alzheimer's disease
This study tests whether a water pill called bumetanide can help people with early Alzheimer's disease. It involves taking the study drug, having MRI scans, and doing memory tests to see if it slows down symptoms.
Stanford, CaliforniaAges 50–85 - NCT06047028Recruiting
Heart MRI scan to assess tissue health
This study uses a special MRI scan to look at heart muscle metabolism in people with heart failure caused by blocked arteries. It may help doctors better understand which heart tissue is still alive and could recover.
Dallas, TexasAges 20–80 - NCT06054516Recruiting
Study of heart metabolism in ischemic heart disease using advanced imaging
This trial uses a special imaging technique (hyperpolarized MRSI) to study metabolism in the heart muscle of people with chronic heart failure caused by ischemic heart disease. It aims to help doctors better understand how the heart uses energy.
Aarhus, Central JutlandAges 18–90 - NCT06032065RecruitingPhase 3
Exercise for peripheral artery disease
This trial tests whether a home-based exercise program is as effective as supervised exercise for improving walking ability in people with peripheral artery disease (PAD). You will be randomly assigned to one of two exercise groups, and you may be asked to drink beetroot juice as part of the study.
Chicago, IllinoisAges 50 years+ - NCT04404114Recruiting
Shear wave ultrasound to tell acute from chronic kidney disease
This study checks whether a special ultrasound can help tell whether kidney problems started suddenly (acute) or have been present longer (chronic). It may help doctors choose the right next steps faster in the emergency room.
TaipeiAges 20 years+ - NCT05800275RecruitingPhase 2
Tucatinib and capecitabine plus spinal trastuzumab for HER2+ cancer
This Phase 2 trial tests a combination of tucatinib and capecitabine (taken by mouth) plus trastuzumab delivered into the spinal fluid, to treat breast cancer that has spread to the leptomeninges (lining around the brain/spinal cord). It may help reduce cancer activity in the spinal fluid and improve symptoms.
BordeauxAges 18 years+ - NCT05960331Recruiting
Study how choice affects learning movement in Parkinson’s
This study looks at whether having more control or “autonomy” helps you learn new movement tasks. It may help researchers find ways to improve physical therapy training for people with Parkinson’s.
TaipeiAges 20 years+ - NCT06018831Recruiting
Kidney screening for newborns
This study offers free urine and ultrasound screening for kidney disease in all newborn infants, with a goal to find and track potential issues early over the first 3 years of life.
Nantong, JiangsuAges Up to 6 years - NCT06023407Enrolling by invitation
Heat therapy for blood sugar and Alzheimer's prevention
This study tests whether regular heat therapy (like sitting in a hot tub) can help improve blood sugar control and lower the risk of Alzheimer's disease in older women who have metabolic problems.
Kansas City, KansasAges 65 years+ - NCT06002581Recruiting
Using brain stimulation to slow Parkinson's disease progression
This study tests if a non-invasive brain stimulation technique called rTMS (repetitive Transcranial Magnetic Stimulation) can slow down Parkinson's disease by improving slow-wave sleep. It aims to help people with mild to moderate Parkinson's who are stable on their medication.
Shanghai, Shanghai MunicipalityAges 50–80 - NCT06008704Recruiting
PET scan study of pain in Parkinson's disease
This study uses a special brain scan (PET) to look at the serotonin system in people with Parkinson's who have chronic pain. The goal is to understand why some people feel pain and how the brain chemical serotonin might be involved.
Toulouse, Haute-GaronneAges 40–80 - NCT06023862RecruitingPhase 2
Study of dostarlimab and bevacizumab for recurrent clear cell cancer
This trial tests a drug called dostarlimab alone or with bevacizumab compared to standard chemotherapy for women whose clear cell cancer of the ovary, uterus, cervix, vagina, or vulva has come back within a year of platinum chemotherapy. The goal is to see if these newer treatments can help control the cancer better.
Clayton, Clayton Rd.Ages 18 years+ - NCT06015191Recruiting
Remote heart rehab for teens with congenital heart disease
This trial tests a home-based cardiac rehab program for adolescents with certain types of congenital heart disease. It aims to help you exercise safely and improve your fitness using online coaching and monitoring.
Kansas City, MissouriAges 12–19
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.